Metabolic
5 compounds in this category.
AOD-9604
Category 1Anti-Obesity Drug 9604, Tyr-hGH Fragment 177-191
A modified fragment of human growth hormone (amino acids 177-191) originally developed as an anti-obesity agent. Targets…
Route
SubQ
Dose
300–500 mcg
Cycle
12–16 weeks
Amlexanox
UnregulatedAphthasol, OraDisc A
An anti-inflammatory and anti-allergic compound originally approved for treating aphthous ulcers (canker sores). Gained …
Route
Oral tablet or topical
Dose
25–50 mg (oral, investigational for metabolic use)
Cycle
8–12 weeks
Setmelanotide
FDA ApprovedImcivree, RM-493
An MC4R (melanocortin 4 receptor) agonist FDA-approved for rare genetic obesity disorders including POMC, PCSK1, and LEP…
Route
SubQ
Dose
1–3 mg (titrated)
Cycle
Ongoing
Tesofensine
InvestigationalNS2330, TE
A triple monoamine reuptake inhibitor (serotonin, norepinephrine, dopamine) originally developed for Parkinson's and Alz…
Route
Oral
Dose
0.25–0.5 mg
Cycle
Ongoing
Pramlintide
FDA ApprovedSymlin, Amylin Analog
A synthetic analog of amylin, a peptide hormone co-secreted with insulin by pancreatic beta cells. FDA-approved as an ad…
Route
SubQ
Dose
15–120 mcg (titrated by diabetes type)
Cycle
Ongoing